{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-23-000404","form_type":"8-K","ticker":"PGEN","cik":"0001356090","company_name":"PRECIGEN, INC.","filed_at":"2023-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.594223+00:00","generated_at":"2026-06-20T15:55:22.305212+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Precigen reports pipeline progress and R&D Day for PRGN-2012 data on Jan 24, 2023","bullets":["PRGN-2012 Phase 2 enrollment rapid; 20 patients enrolled; R&D Day Jan 24 to share Phase 1 data.","PRGN-2009 Phase 2 monotherapy arm near full enrollment: 19 of 20 patients; interim data expected H2 2023.","PRGN-3006 in AML: Phase 1 dose escalation data presented at ASH; Phase 1b expansion includes Mayo Clinic; first repeat dose cleared.","PRGN-3005 in ovarian cancer: Phase 1 dose escalation completed; first repeat dose given; expansion enrollment ongoing.","PRGN-3007 (next-gen UltraCAR-T) trial open for enrollment; first patient dosing expected Q1 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-23-000404","json":"https://secwatch.observer/filing/0000950103-23-000404.json","markdown":"https://secwatch.observer/filing/0000950103-23-000404.md","text":"https://secwatch.observer/filing/0000950103-23-000404.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323000404/0000950103-23-000404-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356090/000095010323000404/dp186955_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T15:55:22.305212+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}